Home/Filings/4/0001567619-21-016820
4//SEC Filing

Dillon Michael P. 4

Accession 0001567619-21-016820

CIK 0001676725other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 6:48 PM ET

Size

5.4 KB

Accession

0001567619-21-016820

Insider Transaction Report

Form 4
Period: 2021-09-02
Dillon Michael P.
SVP, Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2021-09-02$25.09/sh10,000$250,94378,789 total
Footnotes (2)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades in prices ranging from $24.95 to $25.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001777415

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:48 PM ET
Size
5.4 KB